Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis
This study has been completed.
Study NCT00175045   Information provided by Takeda Global Research & Development Center, Inc.

First Received on September 12, 2005.   Last Updated on July 20, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophagitis
Reflux
More general conditions related to this trial
Digestive System Diseases
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Interventions listed in this trial
Lansoprazole
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Takeda Global Research & Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services